Previous Article | Next Article ![]()
Molecular and Cellular Biology, July 2002, p. 4902-4913, Vol. 22, No. 13
0270-7306/02/$04.00+0 DOI: 10.1128/MCB.22.13.4902-4913.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Department of Biochemistry, Robert Wood Johnson Medical School, Piscataway, New Jersey 08854
Received 27 November 2001/ Returned for modification 23 January 2002/ Accepted 6 March 2002
| ABSTRACT |
|---|
|
|
|---|
rpn10
mutant. High-level expression of Rad23 revealed, for the first time, an interaction between ubiquitinated proteins and the proteasome. This increase was not observed in rpn10
mutants, suggesting that Rpn10 participates in the recognition of proteolytic substrates that are delivered by Rad23. Overexpression of UbLR23 caused stabilization of a model substrate, indicating that an unregulated UbLR23-proteasome interaction can interfere with the efficient delivery of proteolytic substrates by Rad23. Because the suppression of a rad23
rpn10
mutant phenotype required both UbLR23 and UBA domains, our findings support the hypothesis that Rad23 encodes a novel regulatory factor that translocates ubiquitinated substrates to the proteasome. | INTRODUCTION |
|---|
|
|
|---|
The addition of purified Rad23 protein to a reconstituted ubiquitination reaction mixture effectively blocked the formation of multi-Ub chains on a test substrate histone, H2B (30, 41). In agreement with this result, we found that the overexpression of Rad23 inhibited the degradation of test substrates in vivo (30). Additionally, it has been shown that overexpression of Rad23 causes stabilization of Pds1 (8). The discovery that Rad23 can bind Ub (5, 7), multi-Ub chains (33, 48), and ubiquitinated proteins (30) provides a mechanistic basis for these findings.
Rad23 contains two Ub-associated (UBA) domains (21, 43) that play an important role in regulating the abundance of the cell cycle regulator Pds1 (5, 8). Recent studies showed that the UBA domains in Rad23, as well as Ddi1 and Dsk2, could interact with Ub and multi-Ub chains (5, 7, 13, 33, 48). Interestingly, Dsk2 and Ddi1 also contain UbL domains, and double mutants (rad23
dsk2
and rad23
ddi1
) display growth defects that are not apparent in the single-mutant strains (6, 8). Similar to results from our studies with Rad23 (30, 35), the Dsk2 protein was recently reported to bind ubiquitinated proteins and the proteasome in yeast cells (13, 33). Collectively, these findings suggest that proteins that contain both UbL and UBA domains represent a novel class of proteolytic regulators that have similar and partially redundant functions.
Rad23 has a role that overlaps with that of Rpn10 (26), a subunit in the proteasome that binds multi-Ub chains (44). Loss of both proteins (rad23
rpn10
) resulted in pleiotropic growth and proteolytic defects that included extreme sensitivity to cold temperatures and inability to grow in the presence of amino acid analog canavanine (26). In addition, ubiquitinated proteins accumulated in the double mutant, suggesting a failure in their delivery to the proteasome. In agreement with this conjecture, we found that
UbLrad23 (a mutant lacking the UbL domain) could bind ubiquitinated proteins but was unable to alleviate any of the defects of a rad23
rpn10
mutant, underscoring the importance of the Rad23-proteasome interaction.
We report here that Rad23 can bind ubiquitinated cellular proteins. Significantly, this interaction required the UBA domains, since specific mutants were deficient in binding ubiquitinated cellular proteins. Because Rad23 mutants that lacked either UbLR23 or functional UBA domains failed to suppress the defects of rad23
rpn10
mutants, we conclude that the interactions with both ubiquitinated proteins and the proteasome are required for Rad23 function. High-level expression of Rad23 resulted in a dramatic increase in the levels of ubiquitinated proteins in the proteasome. Furthermore, the increased association between ubiquitinated proteins and the proteasome required Rpn10. These intriguing results are to our knowledge the first evidence that reveals the interaction between ubiquitinated proteins and the proteasome. Collectively, our results provide compelling support for a "shuttle factor hypothesis," wherein Rad23 and other proteins that contain UbL and UBA domains, such as Dsk2 (6) and Ddi1 (8), regulate the translocation of proteolytic substrates to the proteasome. As a further test of this idea, we found that overexpression of GST-UbLR23 resulted in significant stabilization of a test substrate, suggesting that unregulated interaction between UbLR23 and the proteasome can interfere with the efficient delivery of proteolytic substrates by Rad23.
| MATERIALS AND METHODS |
|---|
|
|
|---|
mutant was constructed with plasmid pJGSST1 in haploid yeast strain JD47-13C (MATa his3-
200 trp1-
63 lys2-801 ura3-52 leu2-112), which was kindly provided by J. Dohmen. The yeast RAD23 gene was deleted in JD47-13C by using plasmid pDG28, which was provided by R. D. Gietz. KMY1188 is an 5-fluoroorotic acid-resistant derivative of this rad23
strain. Plasmids expressing Flag-Rad23 and the set of glutathione S-transferase (GST)-Rad23 fusion proteins were described previously (35).
Protein and immunological methods.
Pulse-chase and immunoblotting experiments were performed essentially as described previously (2, 30). Briefly, exponential-stage yeast cells (
30 ml; A600 = 1) were washed and suspended in labeling buffer containing 250 µCi of a [35S]Met-[35S]Cys (NEN/Dupont) combination and incubated for 5 min at 30°C. The incorporation of radioisotope was terminated by suspending the cells in medium containing 0.5 mg of cycloheximide/ml and excess unlabeled methionine and cysteine. Aliquots were withdrawn at intervals and frozen in liquid nitrogen. After aliquots from all the time points were collected, 0.5-mm acid-washed glass beads (Sigma Chemical Co., St. Louis, Mo.) were added and the cells were lysed by vortexing. The incorporation of 35S label into trichloroacetic acid (TCA)-insoluble material was determined by scintillation counting, and equal amounts of protein were adjusted to equal volume and incubated with specific antibodies. Immunoprecipitations were typically carried out for 3 h at 4°C with constant mixing. The bound proteins were washed, resuspended in sodium dodecyl sulfate (SDS)-sample buffer, boiled, and resolved in SDS-containing polyacrylamide gels. Experiments involving the characterization of ß-galactosidase (ß-Gal) test proteins were performed using 8% polyacrylamide gels, while 10% acrylamide gels were used in all other experiments. The separated proteins were transferred to nitrocellulose with a Hoefer semidry transfer apparatus and blocked with 5% milk powder. Antibodies against ß-Gal were purchased from Promega Inc. (Madison, Wis.). Anti-Flag, anti-Ub, and anti-GST antibodies were purchased from Sigma Chemical Co. Antibodies against GST-Rad23 were prepared by Pocono Rabbit Co. For immunoblot detection, an enhanced chemiluminescence kit was purchased from NEN/Dupont. Protein A-Sepharose was purchased from Repligen Inc. (Cambridge, Mass.), and GST-Sepharose was purchased from Amersham/Pharmacia Biotech (Piscataway, N.J.). Protein interactions were quantitated with Kodak 1D-3.5 software.
Cell-cycle analysis. The growth of yeast bar1-1 mutant cells (4910-3-3a; MATa cdc7-4 his7 ura1 bar1) was arrested by adding 10 ng of alpha-factor (Sigma)/ml. The efficiency of arrest was determined microscopically, and after greater than 95% of the cells had arrested in G1 they were resuspended in fresh medium lacking alpha-factor to resume mitotic growth. An aliquot of the culture was withdrawn immediately after resuspension and suspended for 5 min in labeling buffer containing 200 µCi of a [35S]Met-[35S]Cys combination. Further incorporation of 35S label was terminated by the addition of cycloheximide, and the cells were incubated for further 60 min (chase). Equal-volume aliquots were removed during the chase after 0, 10, and 60 min and frozen in liquid nitrogen. Similar pulse-chase experiments were performed at 30-min intervals five additional times during the cell cycle. Equal amounts of TCA-insoluble material were reacted with antibodies against native Rad23, and the precipitated proteins were separated by SDS-polyacrylamide gel electrophoresis (PAGE), transferred to nitrocellulose, and exposed to X-ray film. The same filter was subsequently incubated with antibodies against Ub, and the cross-reacting material was detected by enhanced chemiluminescence.
Construction of RAD23 mutations. DNA oligonucleotides to delete the UBA1 domain or to generate mutations in UBA1 and UBA2 domains of yeast RAD23 were synthesized. Oligonucleotides complementary to the 5' and 3' ends of the RAD23 gene contained EcoRI and KpnI DNA restriction sites for cloning into a yeast expression vector that encoded a Flag epitope. However, for expression of the same RAD23 alleles in E. coli we amplified the DNA with oligonucleotides that contained NcoI and BamHI DNA restriction sites on the 5' and 3' ends and cloned the DNA into pET11d (Novogen, Inc.). The oligonucleotides used for generating the UBA mutations are shown below, and the mutated genes were subjected to DNA sequencing for confirmation. The primers used for generating a deletion of UBA1, described previously (30), were 461 (5'-GAATATGCACTGATGGGTATTCCAG-3'), 462 (5'-GAATACCCATCAGTGCATATTCCACCGC-3'), and 470 (5'-GCGGATCCTCAGTCGGCATGATCGCTGAATGCGATATTTGCTGCAGC-3')
| RESULTS |
|---|
|
|
|---|
|
UbLrad23; lane 3) formed a strong interaction with ubiquitinated proteins. In contrast, ubiquitinated proteins were not copurified with GST-UbLR23 (lane 4), although this domain forms a strong interaction with the proteasome, which recognizes and degrades ubiquitinated proteins. It is likely that ubiquitinated substrates are normally not detected in association with the proteasome because they are rapidly degraded. Similar to GST-UbLR23, ubiquitinated proteins were not purified with GST (lane 1).
UBA domains in Rad23 mediate the interaction with ubiquitinated proteins.
The UBA domains in Rad23 (43) and other proteins bind Ub (5, 7, 13, 33, 48). In addition, ubiquitinated proteins could be coprecipitated with Rad23 and Dsk2 from yeast cell extracts (13, 30). To further characterize the interaction between the UBA domains in Rad23 and Ub, we generated a set of mutants that were based on studies described previously (5). We deleted UBA1 in Rad23 and also generated mutants that contained single amino acid substitutions in each UBA domain to prevent their interaction with Ub. Each derivative was expressed with an amino-terminal Flag epitope to facilitate rapid purification from yeast cells. (Flag-Rad23 can functionally replace the native protein.) In agreement with the results in Fig. 1C, ubiquitinated proteins were efficiently copurified with Flag-Rad23 (Fig. 1D, lane 1). However, a single amino acid substitution in UBA1 (L183A; rad23uba1) caused an 80% reduction in the amount of ubiquitinated protein that was recovered (lane 2). In contrast, a similar mutation in UBA2 (L392A; rad23uba2) decreased the binding by only 20% (lane 3), consistent with a weaker interaction with Ub, which was previously described (5, 7). A Rad23 mutant that contained mutations in both UBA domains (rad23uba1uba2) was completely defective (lane 4), and the interaction with ubiquitinated proteins was
1% of that detected with the wild-type protein. In contrast to the single amino acid substitution in UBA1 (rad23uba1), deletion of the entire domain (rad23
uba1; removal of residues 141 to 190) caused a very severe defect (lane 6), and the interaction with ubiquitinated proteins was
1% of the level seen with the wild-type protein, despite the presence of intact UBA2. Since the UBA domains in Rad23 have been reported to participate in the formation of homodimers (4, 5), it is possible that they contribute to the conformational integrity of the protein, and a deletion could cause significant structural perturbations. Similarly, dimerization between Rad23 and other UBA-containing proteins (33) might also contribute to its stabilization. Removal of UbLR23 (
UbLrad23), which is believed to form an independently folded domain (35; our unpublished studies), did not affect the interaction with ubiquitinated proteins (lane 5). The same filter was also incubated with antibodies against Cim5/Rpt1 (35), one of the six ATPases present in the 19S regulatory particle of the proteasome (16). With the exception of
UbLrad23 (Fig. 1E, lane 5), all the Rad23 derivatives contained UbLR23 and were able to bind the proteasome (Fig. 1E). The ability of the
UbLrad23 mutant to bind ubiquitinated proteins but not the proteasome is consistent with the idea that shuttle factors deliver proteolytic substrates to the proteasome. We examined the interaction between Flag-Rad23 and well-characterized proteolytic substrates to establish that the anti-Ub cross-reacting material that coprecipitated with Flag-Rad23 included proteolytic substrates (and not just unanchored multi-Ub chains). Plasmids that expressed the test substrates Ub-Pro-ß-Gal and Arg-ß-Gal and the control protein Met-ß-Gal were transformed into a yeast strain that harbored the Flag-Rad23-expressing construct. Yeast extracts were prepared and applied to Flag-agarose beads, and the interaction with the ß-Gal substrates was determined by immunoblotting (Fig. 1F). As expected, we found that well-characterized proteolytic substrates Ub-Pro-ß-Gal and Arg-ß-Gal (2, 45) coprecipitated with Flag-Rad23 (lanes 2 and 3) but not with Met-ß-Gal, which is not targeted for degradation (lane 1). The human counterparts of Rad23 (hHR23-A and hHR23-B) can also bind the proteasome (35) and block the assembly of substrate-linked multi-Ub chains (30). To further assess their similarity with the yeast protein, we expressed GST-hHR23-B in yeast and found that ubiquitinated proteins were copurified (Fig. 1G, lane 1). Since the sequence and structure of Ub are highly conserved between yeast and humans, these results suggest that the UBA domains in Rad23 proteins play an evolutionarily conserved role in binding ubiquitinated proteins.
UBA mutants fail to stabilize substrates in vivo.
We next investigated if mutations in the UBA domains had an effect on the biochemical properties of Rad23. We first measured the binding between the mutant Rad23 proteins and proteolytic substrates Arg-ß-Gal and Ub-Pro-ß-Gal. Flag-Rad23 and Flag-rad23uba2 could efficiently coimmunoprecipitate ubiquitinated Ub-Pro-ß-Gal (Fig. 2A, lanes 2 and 11) and Arg-ß-Gal (lanes 3 and 12) but not the control substrate Met-ß-Gal (lanes 1 and 10). In contrast, Rad23 derivatives that contained mutations in UBA1 were significantly more impaired in binding these substrates (Fig. 2A, lanes 4 to 9 and 13 to 15) in proportion to their ability to interact with ubiquitinated cellular proteins (Fig. 1D). In contrast to Flag-rad23uba2, Flag-rad23
uba1 and Flag-rad23uba1uba2 interacted poorly with Arg-ß-Gal and Ub-Pro-ß-Gal. In the experiment shown in Fig. 2A, the cellular levels of Flag-rad23uba1, Flag-rad23uba2, and Flag-rad23uba1uba2 mutant proteins were approximately threefold higher than the level of Flag-Rad23, accounting for the higher levels of bound substrates. (Figure 2B is a Ponceau-S-stained filter that was subsequently immunoblotted in Fig. 2A.) For reasons that are not clear, the single amino acid substitution in rad23uba2 resulted in a noticeable decrease in electrophoretic mobility (Fig. 2B, lanes 10 to 15). However, it should be noted that native Rad23 also displays aberrant mobility in SDS-polyacrylamide gels, as it is typically detected as a 58- to 60-kDa protein despite a predicted size of 42 kDa. (A cross-reacting band that comigrated with Met-ß-Gal was detected by immunoblotting, but not following pulse-chase analysis and immunoprecipitation, as shown in Fig. 2C.)
|
7 min; Fig. 2C, lanes 1 to 4), while overexpression of Flag-Rad23 prevented the expansion of multi-Ub chains on Ub-Pro-ß-Gal (lanes 5 to 8), resulting in strong stabilization (t1/2, >100 min). In contrast to Flag-Rad23, Flag-rad23uba1uba2 did not inhibit the multiubiquitination and degradation of Ub-Pro-ß-Gal (t1/2,
10 min; lanes 9 to 12), demonstrating that the interaction between UBA domains in Rad23 and Ub moieties on a substrate is important for controlling protein stability. Rad23 forms transient interactions with ubiquitinated proteins. In previous studies we reported that Rad23 and another DNA repair protein, Rad4, could be cofractionated with the proteasome (35). Based on this result we speculated that Rad23 might translocate proteolytic substrates to the proteasome, although it is not known if Rad4 is a substrate for degradation. We also observed that high-level expression of Rad23 resulted in the stabilization of well-characterized proteolytic substrates in vivo (30). One interpretation of this result is that, at high-level expression, free Rad23 (representing the fraction that is not bound to substrate) binds the proteasome and interferes with the efficient delivery of proteolytic substrates, resulting in their stabilization. However, at physiological levels of expression, Rad23 might form transient interactions with substrates to facilitate their delivery to the proteasome. This conjecture is supported by the ability of Rad23 to bind Ub (5, 7) and multi-Ub chains (33, 48) and its overlapping functions with Rpn10 (26). To test this idea, we measured the interaction between Rad23 and ubiquitinated proteins in a time course assay. The growth of yeast cells was inhibited in G1 phase by the addition of alpha-mating factor to the medium (27). The culture was released from G1 arrest and allowed to grow synchronously for approximately two generations, during which time we conducted pulse-chase analysis at 30-min intervals to measure the interaction between ubiquitinated proteins and native Rad23 protein. We found that Rad23 formed an association with high-molecular-weight, 35S-labeled material throughout the cell cycle (Fig. 3A, zero time point lanes). As noted previously, native Rad23 is stable (47), despite its interaction with the proteasome (35). When the same filter was incubated with anti-Ub antibodies, we detected a strong reaction against high-molecular-weight species (Fig. 3B), consistent with the hypothesis that Rad23 forms transient interactions with cellular proteins that are ubiquitinated. Significantly, the interaction between Rad23 and ubiquitinated proteins decreased rapidly during the chase (compare intensities in the 0- and 60-min lanes). We speculate that this decrease in anti-Ub cross-reacting material might reflect proteasome-mediated degradation of the proteins that are bound to Rad23. However, we cannot discount the possibility that the decrease results from the dissociation of the bound ubiquitinated proteins or the action of de-ubiquitinating enzymes.
|
To explore the link between NER and proteolysis, we examined Rad23 interaction with ubiquitinated proteins following DNA damage. An actively growing culture of yeast cells was exposed to the UV mimetic 4-nitrosoquinoline oxide (4-NQO) or to alpha-mating factor. Protein extracts were prepared, and Flag-Rad23 was precipitated. The proteins were separated by SDS-PAGE, transferred to nitrocellulose, and incubated with antibodies against Ub. Equivalent amounts of ubiquitinated proteins were bound to Flag-Rad23 in untreated and alpha-factor-treated cells (Fig. 4A, lanes 2 and 3). In contrast, the interaction between Rad23 and ubiquitinated proteins increased approximately twofold after treatment with 4-NQO (lane 1). (The quantitation of these results was adjusted for the amount of Flag-Rad23 that was precipitated.) The relatively modest increase in interaction with ubiquitinated proteins following DNA damage may reflect the fact that Rad23 participates in diverse pathways including stress response, cell cycle control, and DNA repair. Therefore, a twofold increase may be quite significant if it arises exclusively from increased levels of DNA repair-specific targets. To further characterize the effect of DNA damage, we compared the binding between ubiquitinated proteins and either Flag-Rad23 or Flag-
UbLrad23, a mutant that causes a defect in DNA repair (47). Yeast cells that expressed either Flag-Rad23 or Flag-
UbLrad23 were exposed to 4-NQO for 60 min and then resuspended in medium lacking this DNA-damaging agent. Aliquots of the culture were withdrawn after 0, 10, 30, and 60 min, and protein extracts were prepared. Equal amounts of protein were incubated with Flag-agarose, and the ubiquitinated proteins that were bound to Rad23 were detected by immunoblotting (Fig. 4B and E). We found that the overall amount of ubiquitinated proteins that was bound to Rad23 decreased over the 60-min duration. Intriguingly, we observed that the ubiquitinated species that were bound to Flag-Rad23 were redistributed toward higher-molecular-weight forms during the course of the incubation (Fig. 4B). The interaction between Rad23 and the proteasome was unaffected, as revealed by the precipitation of Cim5/Rpt1 (Fig. 4C). In contrast to these results, the ubiquitinated species that were bound to Flag-
UbLrad23 were more heterogeneous in size (Fig. 4E), and we did not observe a significant redistribution to higher-molecular-weight forms (Fig. 4E). As expected, Flag-
UbLrad23 did not show an appreciable interaction with the proteasome (Fig. 4F). The filters used for Fig. 4D and G (which are the same as those used for Fig. 4B and E) were probed with anti-Rad23 antibodies, and the positions of Flag-Rad23 and Flag-
UbLrad23 are indicated. Since substrate-ubiquitinating factors are present in the proteasome (40, 46, 49), these findings raise the possibility that the complete ubiquitination of some proteolytic substrates might occur after their translocation to the proteasome by Rad23.
|
rpn10
double mutant.
The rad23
rpn10
double mutant is unable to grow in the presence of amino acid analog canavanine or at low temperature (26). The rad23
rpn10
mutant also displays proteolytic defects and a delay during the G2 phase of the cell cycle. These pleiotropic phenotypes are completely suppressed following transformation with a plasmid that encodes either Rad23 or Rpn10 (26). To determine if the Rad23-proteasome interaction played a role in this suppression, we previously expressed
UbLrad23 in the rad23
rpn10
mutant and found that it was unable to alleviate any of the defects (26), underscoring the importance of proteasome interaction for Rad23 function. Here we investigated if the interaction between Rad23 and ubiquitinated proteins was also required for suppressing the defects of the rad23
rpn10
mutant. We expressed Flag-rad23uba1uba2 in the rad23
rpn10
mutant and found that it was unable to restore growth at low temperature or in the presence of amino acid analog canavanine (Fig. 5). A mutation in UBA2 enabled Flag-rad23uba2 to grow well at 30 and 23°C but not at 13°C, consistent with its moderate interaction with ubiquitinated proteins (Fig. 1D). In contrast, Flag-rad23uba1uba2 was as growth impaired as the rad23
rpn10
mutant at 30, 23, and 13°C, reflecting its reduced interaction with ubiquitinated cellular proteins. Interestingly, both mutant proteins failed to permit growth in medium containing canavanine, indicating that the generation of damaged proteins by amino acid analogs requires a fully functional Rad23 protein. Taken together, our genetic and biochemical results reveal a correspondence between the biological activity of Rad23 and the efficiency of its interaction with ubiquitinated proteins.
|
|
Our previous genetic studies showed that Rad23 and Rpn10 are both required for efficient stress tolerance and intracellular proteolysis (26). These results are in agreement with biochemical studies, which showed that the UbL domain in human Rad23 can bind S5a (20), the counterpart of yeast Rpn10. However, because Rad23 can interact with the proteasome in rpn10
cells, it is likely that it can bind multiple subunits in the proteasome. We investigated if Rpn10 contributed to the recognition of ubiquitinated substrates by the proteasome because of the inability of Rad23 mutants to suppress the defects of the rad23
rpn10
mutant. We expressed an epitope-tagged proteasome subunit (Pre1-Flag) in wild-type and rpn10
cells, as well as a plasmid that expressed RAD23 at high levels from the galactose-inducible GAL1 promoter. Proteasomes were immunopurified on Flag-agarose, and the proteins were separated by SDS-PAGE, transferred to nitrocellulose, and incubated with anti-Ub antibodies. Low levels of ubiquitinated proteins were associated with proteasomes that were immunoprecipitated from wild-type cells (Fig. 6B, lane 1). In contrast, much lower levels of ubiquitinated cellular proteins were bound to proteasomes that were purified from rpn10
cells (lane 3), which may be due to the absence of this multi-Ub chain-binding protein. Alternatively, proteasomes have been reported to be unstable in rpn10
cells (15), which could result in poor recovery of intact proteasomes and any bound ubiquitinated substrates. Significantly larger amounts of ubiquitinated proteins were precipitated with the proteasome when Rad23 was overexpressed in a wild-type cell (lane 2). Remarkably, a similar increase was not detected when Rad23 was overexpressed in a strain that lacked Rpn10 (rpn10
strain; lane 4). This result is all the more striking given that the high expression of Rad23 in rpn10
cells resulted in dramatically increased amounts of intracellular ubiquitinated proteins (lane 8). Collectively, our results support the hypothesis that Rad23 binds ubiquitinated substrates and regulates their delivery to Rpn10 in the proteasome.
We expressed high levels of either GST or GST-UbLR23 (Fig. 1B, lanes 1 and 4) in a strain that also expressed Ub-Pro-ß-Gal to further explore the idea that Rad23 translocates proteolytic substrates to the proteasome. Based on the assumption that the interaction between UbLR23 and the proteasome might block the delivery of substrates, we performed a pulse-chase analysis to measure Ub-Pro-ß-Gal stability in the presence of high levels of UbLR23. Actively growing yeast cells were metabolically labeled with [35S]Met-[35S]Cys for 5 min, and translation was terminated by the addition of cycloheximide and unlabeled methionine and cysteine. Equal amounts of labeled cellular protein were incubated with anti-ß-Gal antibodies, and the precipitated material was resolved by SDS-PAGE and visualized by autoradiography. We found that the stability of Ub-Pro-ß-Gal was slightly less than 7 min in a strain that expressed GST, consistent with the results in Fig. 2C. In contrast, the stability of this substrate was increased dramatically (to
41 min) in cells that contained high levels of UbLR23, supporting the idea that unregulated UbLR23-proteasome interaction can interfere with the delivery of proteolytic substrates to the proteasome.
| DISCUSSION |
|---|
|
|
|---|
The expression of high levels of Rad23 resulted in the accumulation of ubiquitinated proteins in yeast cells. The UBA domains in Rad23 are required for the interaction with ubiquitinated cellular proteins, and mutants that were unable to bind ubiquitinated proteins displayed biochemical and physiological defects. The interaction between Rad23 and ubiquitinated proteins increased transiently after DNA damage, and these ubiquitinated proteins were converted to higher-molecular-weight derivatives over time. In contrast, a Rad23 mutant that was unable to bind the proteasome (
UbLrad23) formed a persistent interaction with ubiquitinated proteins, with no significant increase in the formation of higher-molecular-weight conjugates. One interpretation of this result is that, for some substrates, complete assembly of a multi-Ub chain might require an interaction with the proteasome (40).
The role of Rad23 overlaps with that of Rpn10 (26), a subunit in the proteasome that binds multi-Ub chains (44). Rad23 mutants that are unable to bind ubiquitinated proteins failed to stabilize test substrates in vivo or suppress the proteolytic and growth defects of a rad23
rpn10
mutant. Consistent with previous in vitro studies, we discovered that ubiquitinated proteins in yeast protein extracts could be copurified with Flag-Rpn10. Rad23 and Rpn10 contain different Ub-binding domains and might interact with structurally distinct features within a multi-Ub chain. Although we previously showed that Rad23 could bind short, substrate-linked multi-Ub chains, the results shown here also suggest that Rad23 might bind substrates that contain longer multi-Ub chains. We note that the distal Ub moieties in a long multi-Ub chain are not tightly packed and may resemble a short, substrate-linked multi-Ub chain (9). In contrast, Rpn10 recognizes a hydrophobic patch that is formed by the compaction of Ub moieties in a long lysine-48-linked multi-Ub chain (3, 39). The interaction between Rad23 and a multi-Ub chain might prevent dismantling by Ub-specific proteases, resulting in transient stabilization of the substrate, consistent with our in vitro and in vivo data (30). Subsequent delivery of the ubiquitinated substrate by Rad23 to Rpn10 in the proteasome could initiate degradation. We note that a recent study demonstrated that Rad23 specifically interacted with multi-Ub chains in vivo and displayed specificity only for chains that promote the degradation of proteins by the proteasome (33).
To examine the role of Rad23 and Rpn10 in the targeting of proteolytic substrates, we immunoprecipitated proteasomes from rpn10
and wild-type cells using an epitope-tagged subunit in the 20S core particle (Pre1-Flag). A low level of ubiquitinated proteins was coprecipitated with proteasomes from a wild-type strain. In contrast, much lower levels of ubiquitinated proteins were detected in proteasomes that were isolated from the rpn10
mutant, consistent with the well-characterized interaction of Rpn10 with multi-Ub chains. The levels of proteasome-associated ubiquitinated proteins increased dramatically when Rad23 was overexpressed, supporting the idea that it might deliver substrates to the proteasome. Significantly, overexpression of Rad23 in rpn10
cells resulted in the accumulation of very high levels of intracellular ubiquitinated proteins, although these ubiquitinated proteins could not be copurified with the proteasome. A plausible interpretation of these results is that the high levels of ubiquitinated proteins that arise from overexpression of Rad23 are not efficiently delivered to the proteasome in rpn10
cells. Under normal conditions, the Rad23-proteasome interaction may allow substrates to be transferred to Rpn10 to initiate further ubiquitination by proteasome-associated E3 (49) and E2 (40) factors. A failure to efficiently deliver ubiquitinated substrates to the proteasome could underlie the pleiotropic growth and proteolytic defects of the rad23
rpn10
mutant.
Collectively, our findings provide compelling evidence that the proteasome recognizes multiubiquitinated substrates. Although a variety of genetic and biochemical approaches have shown that multiubiquitinated proteins are targeted to the proteasome, it has not been possible to clearly demonstrate the interaction between proteolytic substrates and the proteasome. Our findings predict important roles for both the UbLR23 and UBA domains of Rad23 in the translocation of proteolytic substrates to the proteasome. Since the role of Rad23 overlaps with those of other proteins that contain both UbL and UBA domains (Ddi1 [8] and Dsk2 [6, 33]), we speculate that this class of proteins may encode novel regulators that deliver substrates to the proteasome. Our current understanding of Rad23 function can be represented by a simple model in which Rad23 (and other proteins that contain both UbL and UBA domains) are shuttle factors that translocate proteolytic substrates to the proteasome (Fig. 7). In agreement with the shuttle factor model, we note that Rad23 can be cofractionated with Rad4 and the 26S proteasome (35) and can also promote the translocation of Png1 to the proteasome (38). A recent study has also reported that Rad23 controls the abundance of cell cycle regulator Pds1 (5, 8). The failure to control Pds1 levels may account, in part, for the G2-to-M phase transition defect of the rad23
rpn10
mutant.
|
| ADDENDUM IN PROOF |
|---|
|
|
|---|
| ACKNOWLEDGMENTS |
|---|
This study was supported by Public Health Service grant CA-83875 from the National Cancer Institute.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
2.
Bachmair, A., D. Finley, and A. Varshavsky. 1986. In vivo half-life of a protein is a function of its amino-terminal residue. Science 234:179-186.
3. Beal, R. E., D. Toscano-Cantaffa, P. Young, M. Rechsteiner, and C. M. Pickart. 1998. The hydrophobic effect contributes to polyubiquitin chain recognition. Biochemistry 37:2925-2934.[CrossRef][Medline]
4. Bertolaet, B. L., D. J. Clarke, M. Wolff, M. H. Watson, M. Henze, G. Divita, and S. I. Reed. 2001. UBA domains mediate protein-protein interactions between two DNA damage-inducible proteins. J. Mol. Biol. 313:955-963.[CrossRef][Medline]
5. Bertolaet, B. L., D. J. Clarke, M. Wolff, M. H. Watson, M. Henze, G. Divita, and S. I. Reed. 2001. UBA domains of DNA damage-inducible proteins interact with ubiquitin. Nat. Struct. Biol. 8:417-422.[CrossRef][Medline]
6.
Biggins, S., I. Ivanovska, and R. D. Rose. 1996. Yeast ubiquitin-like genes are involved in duplication of the microtubule organizing center. J. Cell Biol. 133:1331-1346.
7. Chen, L., U. Shinde, T. G. Ortolan, and K. Madura. 2001. Ubiquitin-associated (UBA) domains in Rad23 bind ubiquitin and promote inhibition of multi-ubiquitin chain assembly. EMBO Rep. 2:933-938.[CrossRef][Medline]
8.
Clarke, D. J., G. Mondesert, M. Segal, B. L. Bertolaet, S. Jensen, M. Wolff, M. Henze, and S. I. Reed. 2001. Dosage suppressors of pds1 implicate ubiquitin-associated domains in checkpoint control. Mol. Cell. Biol. 21:1997-2007.
9.
Cook, W. J., L. C. Jeffrey, M. Carson, Z. Chen, and C. M. Pickart. 1992. Structure of a diubiquitin conjugate and a model for interaction with ubiquitin conjugating enzyme (E2). J. Biol. Chem. 267:16467-16471.
10.
Deveraux, Q., V. Ustrell, C. Pickart, and M. Rechsteiner. 1994. A 26S protease subunit that binds ubiquitin conjugates. J. Biol. Chem. 269:7059-7061.
11.
Fu, H., S. Sadis, D. M. Rubin, M. Glickman, S. van Nocker, D. Finley, and R. D. Vierstra. 1998. Multiubiquitin chain binding and protein degradation are mediated by distinct domains within the 26S proteasome subunit Mcb1. J. Biol. Chem. 273:1970-1981.
12. Funakoshi, M., S. Geley, T. Hunt, T. Nishimoto, and H. Kobayashi. 1999. Identification of XDRP1; a Xenopus protein related to yeast Dsk2p binds to the N-terminus of cyclin A and inhibits its degradation. EMBO J. 18:5009-5018.[CrossRef][Medline]
13.
Funakoshi, M., T. Sasaki, T. Nishimoto, and H. Kobayashi. 2002. Budding yeast Dsk2p is a polyubiquitin-binding protein that can interact with the proteasome. Proc. Natl. Acad. Sci. USA 99:745-750.
14.
Gillette, T. G., W. Huang, S. J. Russell, S. H. Reed, S. A. Johnston, and E. C. Friedberg. 2001. The 19S complex of the proteasome regulates nucleotide excision repair in yeast. Genes Dev. 15:1528-1539.
15. Glickman, M. H., D. M. Rubin, O. Coux, I. Wefes, G. Pfeifer, Z. Cjeka, W. Baumeister, V. A. Fried, and D. Finley. 1998. A subcomplex of the proteasome regulatory particle required for ubiquitin-conjugate degradation and related to the COP9-signalosome and eIF3. Cell 94:615-624.[CrossRef][Medline]
16.
Glickman, M. H., D. M. Rubin, V. A. Fried, and D. Finley. 1998. The regulatory particle of the Saccharomyces cerevisiae proteasome. Mol. Cell. Biol. 18:3149-3162.
17.
Guzder, S. N., V. Bailly, P. Sung, L. Prakash, and S. Prakash. 1995. Yeast DNA repair protein RAD23 promotes complex formation between transcription factor TFIIH and DNA damage recognition factor RAD14. J. Biol. Chem. 270:8385-8388.
18.
Guzder, S. N., Y. Habraken, P. Sung, L. Prakash, and S. Prakash. 1995. Reconstitution of yeast nucleotide excision repair with purified Rad proteins, replication protein A, and transcription factor TFIIH. J. Biol. Chem. 270:12973-12976.
19.
Guzder, S. N., P. Sung, L. Prakash, and S. Prakash. 1998. Affinity of yeast nucleotide excision repair factor 2, consisting of the Rad4 and Rad23 proteins, for ultraviolet damaged DNA. J. Biol. Chem. 273:31541-31546.
20.
Hiyama, H., M. Yokoi, C. Masutani, K. Sugasawa, T. Maekawa, K. Tanaka, J. H. J. Hoeijmakers, and F. Hanaoka. 1999. Interaction of hHR23 with S5a. The ubiquitin-like domain of hHR23 mediates interaction with S5a subunit of 26S proteasome. J. Biol. Chem. 274:28019-28025.
21. Hofman, K., and P. Bucher. 1996. The UBA domain: a sequence motif present in multiple enzyme classes of the ubiquitination pathway. Trends Biochem. Sci. 21:172-173.[CrossRef][Medline]
22.
Jansen, L. E. T., R. A. Verhage, and J. Brouwer. 1998. Preferential binding of yeast Rad4-Rad23 complex to damaged DNA. J. Biol. Chem. 273:33111-33114.
23.
Johnson, E. S., P. C. M. Ma, I. M. Ota, and A. Varshavsky. 1995. A proteolytic pathway that recognizes ubiquitin as a degradation signal. J. Biol. Chem. 270:17442-17456.
24. Kleijnen, M. F., A. H. Shih, P. Zhou, S. Kumar, R. E. Soccio, N. L. Kedersha, G. Gill, and P. M. Howley. 2000. The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome. Mol. Cell 6:409-419.[CrossRef][Medline]
25. Koegl, M., T. Hoppe, S. Schlenker, H. D. Ulrich, T. U. Mayer, and S. Jentsch. 1999. A novel ubiquitination factor, E4, is involved in multiubiquitin chain assembly. Cell 96:635-644.[CrossRef][Medline]
26.
Lambertson, D., L. Chen, and K. Madura. 1999. Pleiotropic growth and proteolytic defects caused by the loss of the proteasome-interacting factors Rad23 and Rpn10 of Saccharomyces cerevisiae. Genetics 153:69-79.
27.
Madura, K., and S. Prakash. 1990. Transcript levels of the Saccharomyces cerevisiae DNA repair gene RAD23 increase in response to UV light and in meiosis but remain constant in the mitotic cell cycle. Nucleic Acids Res. 18:4737-4742.
28. Masutani, C., M. Araki, K. Sugasawa, P. J. van der Spek, A. Yamada, A. Uchida, T. Maekawa, D. Bootsma, J. H. J. Hoeijmakers, and F. Hanaoka. 1997. Identification and characterization of XPC-binding domain of hHR23B. Mol. Cell. Biol. 17:6915-6923.[Abstract]
29.
Mu, D., D. S. Hsu, and A. Sancar. 1996. Reaction mechanism of human DNA repair excision nuclease. J. Biol. Chem. 271:8285-8294.
30. Ortolan, T. G., P. Tongaonkar, D. Lambertson, L. Chen, and K. Madura. 2000. The Rad23 DNA repair protein is a negative regulator of substrate-linked multi-ubiquitin chain assembly. Nat. Cell Biol. 2:601-608.[CrossRef][Medline]
31.
Piotrowski, J., R. Beal, L. Hoffman, K. D. Wilkinson, R. E. Cohen, and C. M. Pickart. 1997. Inhibition of the 26S proteasome by polyubiquitin chains synthesized to have defined lengths. J. Biol. Chem. 272:23712-23721.
32. Prakash, S., and L. Prakash. 2000. Nucleotide excision repair in yeast. Mutat. Res. 30:13-24.
33.
Rao, H., and A. Sastry. 2002. Recognition of specific ubiquitin conjugates is important for the proteolytic functions of the ubiquitin-associated domain proteins Dsk2 and Rad23. J. Biol. Chem. 277:11691-11695.
34. Russell, S. J., S. H. Reed, W. Huang, E. C. Friedberg, and S. A. Johnston. 1999. The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair. Mol. Cell 3:687-695.[CrossRef][Medline]
35. Schauber, C., L. Chen, P. Tongaonkar, I. Vega, D. Lambertson, W. Potts, and K. Madura. 1998. Rad23 links DNA repair to the ubiquitin/proteasome pathway. Nature 391:715-718.[CrossRef][Medline]
36. Sugasawa, K., C. Masutani, A. Uchida, T. Maekawa, P. J. van der Spek, D. Bootsma, J. H. J. Hoeijmakers, and F. Hanaoka. 1996. HHR23B, a human Rad23 homolog, stimulates XPC protein in nucleotide excision repair in vitro. Mol. Cell. Biol. 16:4852-4861.[Abstract]
37. Sugasawa, K., J. M. Y. Ng, C. Masutani, T. Maekawa, A. Uchida, P. J. van der Spek, A. M. P. Eker, S. Rademakers, C. Visser, A. Aboussekhra, R. D. Wood, F. Hanaoka, D. Bootsma, and J. H. J. Hoeijmakers. 1997. Two human homologs of Rad23 are functionally interchangeable in complex formation and stimulation of XPC repair activity. Mol. Cell. Biol. 17:6924-6931.[Abstract]
38.
Suzuki, T., H. Park, M. A. Kwofie, and W. J. Lennarz. 2001. Rad23 provides a link between the Png1 deglycosylating enzyme and the 26S proteasome in yeast. J. Biol. Chem. 276:21601-21607.
39. Thrower, J. S., L. Hoffman, M. Rechsteiner, and C. M. Pickart. 2000. Recognition of the polyubiquitin proteolytic signal. EMBO J. 19:94-102.[CrossRef][Medline]
40.
Tongaonkar, P., L. Chen, D. Lambertson, B. Ko, and K. Madura. 2000. Evidence for an interaction between ubiquitin-conjugating enzymes and the 26S proteasome. Mol. Cell. Biol. 20:4691-4698.
41. Tongaonkar, P., and K. Madura. 1998. Reconstituting ubiquitination reactions with affinity-purified components and 32P-ubiquitin. Anal. Biochem. 260:307-319.
42. Uetz, P., L. Giot, G. Cagney, T. A. Mansfield, R. S. Judson, J. R. Knight, D. Lockshon, V. Narayan, M. Srinivasan, P. Pochart, A. Qureshi-Emili, Y. Li, B. Godwin, D. Conover, T. Kalbfleisch, G. Vijayadamodar, M. Yang, M. Johnston, S. Fields, and J. M. Rothberg. 2000. A comprehensive analysis of protein-protein interactions in Saccharomyces cerevisiae. Nature 403:623-631.[CrossRef][Medline]
43. van der Spek, P. J., C. C. Visser, F. Hanaoka, B. Smit, A. Hagemeijer, D. Bootsma, and J. H. J. Hoeijmakers. 1996. Cloning, comparative mapping, and RNA expression of the mouse homologues of the Saccharomyces cerevisiae nucleotide excision repair gene RAD23. Genomics 31:20-27.[CrossRef][